Sandia names new VP for defense research

Monday, Mar 9, 2015 @ 5:50pm by BioPrepWatch Reports

Sandia National Laboratories appointed James Peery to vice president for defense research to continue the lab's national security research efforts. As vice president, Peery will advance development and integration of advanced science and technology to enhance technology systems for the Department of Defense and other areas and agencies.
Read More »

Cubic to support Italian military training

Monday, Mar 9, 2015 @ 3:53pm by BioPrepWatch Reports

Cubic Global Defense was awarded with a supplemental contract of approximately $2.6 million to aid in providing realistic training scenarios for the Italian military, the company announced on Monday.
Read More »

Sandia's anthrax detector recognized with Federal Lab Consortium award

Wednesday, Feb 18, 2015 @ 8:26pm by BioPrepWatch Reports

Sandia National Laboratories announced on Tuesday that their anthrax detection device netted them the Federal Laboratory Consortium's (FLC) 2015 Excellence in Technology Transfer award. The Bacillus anthracis Diagnostics (BaDx) device is no larger than an average credit or debit card and is able to function without electricity and refrigeration, allowing it to be used anywhere with ease.
Read More »

UCSD seeks emergency preparedness coordinator

Monday, Aug 25, 2014 @ 1:09pm by BioPrepWatch Reports

University of California, San Diego is seeking an emergency preparedness coordinator.
Read More »

Aeolus files IND with FDA for radiation countermeasure

Friday, Aug 22, 2014 @ 1:00pm by BioPrepWatch Reports

Aeolus Pharmaceuticals, Inc., announced on Wednesday that it filed an investigational new drug application (IND) with the U.S. Food and Drug Administration to enable a Phase I study of its radiation countermeasure.
Read More »

Data confirms mustard gas countermeasure efficacy

Thursday, Jul 3, 2014 @ 2:00pm by BioPrepWatch Reports

Biotechnology company Aeolus Pharmaceuticals, Inc., released data on Tuesday confirming the efficacy of a mustard gas medical countermeasure.
Read More »

Aeolus publishes data from mustard gas skin treatment study

Monday, Jun 23, 2014 @ 1:30pm by BioPrepWatch Reports

Aeolus Pharmaceuticals, Inc., announced the publication on Wednesday of data from animal model studies that demonstrated the efficacy of its broad-spectrum catalytic antioxidant in treating skin lesions from CEES, a sulfur mustard gas analog.
Read More »

Aeolus produces first batch of AEOL 10150 under BARDA contract

Monday, Feb 17, 2014 @ 3:30pm by BioPrepWatch Reports

Aeolus Pharmaceuticals, Inc., recently announced that it produced its first batch of AEOL 10150 under its advanced research and development contract from the Biomedical Advanced Research and Development Authority.
Read More »

Aeolus files patent application for novel developments of AEOL 10150

Tuesday, Dec 10, 2013 @ 2:30pm by BioPrepWatch Reports

Aeolus Pharmaceuticals, Inc., announced on Thursday that it filed a provisional application regarding new developments with its lead compound, AEOL 10150, with plans to patent-protect its technologies until 2034.
Read More »

Aeolus study reports AEOL 10150 successful against acute radiation lung exposure

Friday, Nov 1, 2013 @ 4:30pm by BioPrepWatch Reports

Aeolus Pharmaceuticals, Inc., announced on Tuesday the results of a U.S. Government funded study concerning the efficacy of the AEOL 10150 drug against acute radiation exposure in the lungs.
Read More »

BARDA exercises additional contract options with Aeolus worth $6 million

Friday, Sep 20, 2013 @ 4:00pm by BioPrepWatch Reports

Aeolus Pharmaceuticals, Inc., announced on Tuesday that the Biomedical Advanced Research and Development Authority has exercised $6 million in additional contract options for the research and development of AEOL-10150.
Read More »

Aeolus Pharmaceuticals awarded $4.3 million grant to combat nerve agents

Monday, Sep 16, 2013 @ 4:30pm by BioPrepWatch Reports

Aeolus Pharmaceuticals, Inc., recently announced that it received a $4.3 million grant from the National Institutes of Health National Institute of Neurological Disorders and Stroke to combat nerve agents.
Read More »

AEOL 10150 treatment shown to improve survival from nitrogen mustard

Wednesday, Jul 3, 2013 @ 4:05pm by BioPrepWatch Reports

Aeolus Pharmaceuticals, Inc., announced on Tuesday the results of its completed studies for AEOL 10150, which showed significant skin protection against nitrogen mustard gas.
Read More »

Aeolus announces positive results of mustard gas treatment study

Monday, Jul 1, 2013 @ 1:35pm by BioPrepWatch Reports

Aeolus Pharmaceuticals, Inc., a Mission Viejo, California-based biotechnology company, announced the completion of two studies on Wednesday that confirm the company's AEOL 10150 product provides significant protection against whole mustard gas.
Read More »

Contract announced for nerve agent countermeasures

Tuesday, Oct 25, 2011 @ 12:29pm by BioPrepWatch Reports

Aeolus Pharmaceuticals, a biotechnology company, announced on Monday that the National Institutes of Health CounterACT program has awarded a $736,951 contract to a University of Colorado scientist to develop medical countermeasures against nerve agents.
Read More »

New compound protects against mustard gas

Thursday, Jul 1, 2010 @ 9:21pm by BioPrepWatch Reports

Aeolus Pharmaceuticals, Inc., announced that in a second study, its lead compound, Aeol 10150, protected rats from lung damage caused by mustard gas.
Read More »